Biomarkers for Disorders

 “Candidate biomarker” is  term   applied to any biological feature related with a disorder. Psychiatric disorders has a long history in search of biomarkers, with recent studies consider molecular markers, like platelet imipramine binding or behavioral markers, such as smooth pursuit eye movements in schizophrenia condition and fear extinction in people with anxiety. Recent searches looking forward to investigate on  blood biomarkers such as brain-derived neurotrophic factor and cytokines in people with schizophrenia or depression and  More high-tech searches such as the use of proteomics to define signatures of proteins that are altered in blood.

More research is going on to investigate  socio-environmental, molecular, neuroimaging  findings related with  Psychiatric disorders such as  Alzheimer disease, schizophrenia  to detect particular signs of the disorder. Most advanced project in this aspect is the Alzheimer’s Disease Neuroimaging Initiative which was funded jointly by the U.S. National Institutes of Health, the pharmaceutical industry and other organizations.

·         Psychiatric Disorders

·         Schizophrenia

·         Bipolar Disorders

·         Alzheimer’s disease /Dementia

·         Depression

Are you interested in

Mail us at

Program Enquiry
biomarkers@molecularbiologyconference.com
Sponsorship/Exhibitor/Advertising
biomarkers@molecularbiologyconference.com
General Queries
biomarkers@molecularbiologyconference.com
More details about sponsorship:sponsors@alliedacademies.com
Copyright © 2018-2019 Allied Academies, All Rights Reserved.